Skip to main content
CRMD logo

CorMedix Inc.

CRMDNASDAQHealthcareBiotechnology

$7.26Today:- (-)1Y −26.72%

As of Oct 16, 2026 close

Market cap
$689.89M
P/E (TTM)
3.69
Forward P/E
1.82
Dividend yield
-
52-week range
$6.13$13.02
Volume (live)
-
Avg. volume (3M)
972.10K

CorMedix (CRMD) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), CorMedix reported total assets of $826.14M and total liabilities of $420.83M. Shareholders' equity was $405.31M, up 378.8% from $84.66M a year earlier. Total debt stood at $146.07M against $148.53M in cash and short-term investments, a net cash position of $2.46M. That puts debt-to-equity at 0.36, compared with 0.01 a year earlier.

CorMedix Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for CorMedix Inc. (CRMD) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents144.8440.6543.6443.3753.3241.9116.5317.6210.38
Short-Term Investments3.6911.0432.3915.6412.154.4411.980.001.60
Cash & Short-Term Investments148.5351.6976.0359.0265.4746.3528.5117.6211.98
Accounts Receivable171.2351.650.000.000.050.000.000.010.06
Inventory29.727.602.110.000.000.140.340.430.59
Other Current Assets17.573.631.310.530.771.410.500.600.63
Total Current Assets367.05114.5879.4559.5566.4748.1829.3518.6713.27
Non-Current Assets
Property, Plant & Equipment (Net)9.932.322.512.382.371.130.130.160.19
Long-Term Investments10.360.000.000.000.000.000.000.000.00
Goodwill30.000.000.000.000.000.000.000.000.00
Intangible Assets379.071.840.000.000.000.000.000.000.00
Other Non-Current Assets40.090.110.100.100.100.000.000.000.00
Total Non-Current Assets459.094.272.612.492.481.130.130.160.19
Total Assets826.14118.8582.0662.0468.9549.3129.4818.8313.45
Current Liabilities
Accounts Payable7.881.724.282.202.211.131.022.591.81
Short-Term Debt1.450.170.150.130.240.110.000.000.00
Accrued Liabilities161.9231.956.973.973.012.92---
Deferred Revenue0.000.000.000.000.000.000.000.010.09
Other Current Liabilities3.0231.956.973.972.892.924.805.174.36
Total Current Liabilities174.2733.8411.406.315.354.165.837.776.26
Non-Current Liabilities
Long-Term Debt144.630.350.520.670.800.920.006.130.00
Other Non-Current Liabilities99.100.000.000.000.000.000.000.000.00
Total Non-Current Liabilities246.570.350.520.670.800.920.006.130.00
Total Liabilities420.8434.1911.926.986.155.095.8313.896.26
Stockholders' Equity
Common Stock0.080.060.050.040.040.030.030.110.07
Retained Earnings-176.58-339.63-321.70-275.36-245.66-217.45-195.42-178.99-152.17
Accumulated Other Comprehensive Income0.000.090.090.080.090.100.100.100.10
Additional Paid-in Capital581.80424.13391.69330.29308.33261.54218.94183.72159.20
Shares Outstanding79.2664.4154.9442.8238.09----
Total Stockholders' Equity405.3184.6670.1455.0662.8044.22-195.42-178.99-152.17
Total Liabilities & Equity826.14118.8582.0662.0468.9549.3129.4818.8313.45

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About CorMedix Balance Sheet

How much debt does CorMedix have?

CorMedix had total debt of $146.07M as of Dec 31, 2025, against $148.53M in cash and short-term investments. Its debt-to-equity ratio was 0.36. Total debt was $517.01K a year earlier.

What are CorMedix's total assets?

CorMedix reported total assets of $826.14M as of Dec 31, 2025, up 595.1% from $118.85M a year earlier. Total liabilities were $420.83M.

What is CorMedix's shareholders' equity?

CorMedix's shareholders' equity was $405.31M as of Dec 31, 2025, or about $5.11 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition